Telemedicine-based KADIS® combined with CGMS™ has high potential for improving outpatient diabetes care

Journal of Diabetes Science and Technology

Volumn 1, Issue 4, 2007, Pages 511-521

  Salzsieder, Eckhard ^a   Augstein, Petra ^a   Vogt, Lutz ^a   Kohnert, Klaus Dieter ^a   Heinke, Peter ^a   Freyse, Ernst Joachim ^a   Ahmed, Abdel Azim ^b   Metwali, Zakia ^b   Salman, Iman ^b   Attef, Omer ^b  

^a Institut fur Diabetes 'Gerhardt Katsch'   (Germany)

^b AJMAN UNIVERSITY   (United Arab Emirates)

Author keywords

Advisory system; Continuous glucose monitoring; Decision support; HbA1c; KADIS; Outpatient diabetes care; Telemedicine

Indexed keywords

EID: 79955139783     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680700100409     Document Type: Article

References (39)

1. Bloomgarden ZT. Glycemic treatment in type 1 and type 2 diabetes. Diabetes Care. 2006 Nov; 29(11):2549-55.
2. Molitch ME, Steffes MW, Cleary PA, Nathan DM. Baseline analysis of renal function in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group [corrected]. Kidney Int. 1993 Mar; 43(3):668-74.
3. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med. 2000 Feb. 10;342(6):381-9.
4. Manley S. Haemoglobin A1c-a marker for complications of type 2 diabetes: the experience from the UK Prospective Diabetes Study (UKPDS). Clin Chem Lab Med. 2003 Sep; 41(9):1182-90.
5. Hollenberg NK. Clinical trials report. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Curr Hypertens Rep. 2004;6:335.
6. Stevens RJ, Coleman RL, Adler AI, Stratton IM, Matthews DR, Holman RR. Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66. Diabetes Care. 2004 Jan; 27(1):201-7.
7. Skyler JS. The economic burden of diabetes and the benefts of improved glycemic control: the potential role of a continuous glucose monitoring system. Diabetes Technol. Ther. 2000;2 Suppl 1:S7-12.
8. Klonoff DC. Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care. 2005 May; 28(5):1231-9.
9. Klonoff DC. A review of continuous glucose monitoring technology. Diabetes Technol Ther. 2005 Oct; 7(5):770-5.
10. Kaufman FR, Austin J, Neinstein A, Jeng L, Halvorson M, Devoe DJ, Pitukcheewanont P. Nocturnal hypoglycemia detected with the Continuous Glucose Monitoring System in pediatric patients with type 1 diabetes. J Pediatr. 2002 Nov; 141(5):625-30.
11. Kaufman FR, Gibson LC, Halvorson M, Carpenter S, Fisher LK, Pitukcheewanont P. A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care. 2001 Dec; 24(12):2030-4.
12. Salzsieder E, Boltz H, Ramirez CJ, Rutscher A, Fischer U, Koenig C. Telematics in diabetes care: application of an advisory program based on routinely monitored self-control data. Diabetologia. 2000;42:A54-97.
13. Rutscher A, Salzsieder E, Thierbach U, Fischer U, Albrecht G. KADIS-a computer-aided decision support system for improving the management of type-I diabetes. Exp Clin Endocrinol. 1990 Feb; 95(1):137-47.
14. Rutscher A, Salzsieder E, Fischer U. KADIS: model-aided education in type I diabetes. Karlsburg Diabetes Management System. Comput Methods Programs Biomed. 1994 Jan; 41(3-4):205-15.
15. Salzsieder E, Albrecht G, Fischer U, Rutscher A, Thierbach U. Computer-aided systems in the management of type I diabetes: the application of a model-based strategy. Comput Methods Programs Biomed. 1990 Jul-Aug; 32(3-4):215-24.
16. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000 Aug. 12;321(7258):405-12.
17. Stevens RJ, Coleman RL, Adler AI, Stratton IM, Matthews DR, Holman RR. Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66. Diabetes Care. 2004 Jan; 27(1):201-7.
18. Salzsieder E, Vogt L, Seidel S, Augstein P. Telemedicine-based diabetes disease management program to support out-patient diabetes care. Diabetologia. 2003;46:A426.
19. Plougmann S, Hejlesen OK, Cavan DA. DiasNet-a diabetes advisory system for communication and education via the internet. Int J Med Inform. 2001 Dec; 64(2-3):319-30.
20. Albisser AM, Sakkal S, Wright C. Home blood glucose prediction: validation, safety, and efficacy testing in clinical diabetes. Diabetes Technol Ther. 2005 Jun; 7(3):487-96.
21. Ludvigsson J, Hanas R. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics. 2003 May; 111(5 Pt 1):933-8.
22. Chico A, Vidal-Rios P, Subira M, Novials A. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care. 2003 Apr; 26(4):1153-7.
23. Melki V, Ayon F, Fernandez M, Hanaire-Broutin H. Value and limitations of the Continuous Glucose Monitoring System in the management of type 1 diabetes. Diabetes Metab. 2006 Apr; 32(2):123-9.
24. Phillips PJ, Phillipov G. A1C-frequently asked questions. Aust Fam Physician. 2005 Aug; 34(8):663-7.
25. Stevens R, Adler A, Gray A, Briggs A, Holman R. Life-expectancy projection by modelling and computer simulation (UKPDS 46). Diabetes Res Clin Pract. 2000 Nov; 50 Suppl 3:S5-13.
26. Watkins P. The UKPDS. A model for gathering the evidence for the management of chronic diseases. UK Prospective Diabetes Study Group. J R Coll Physicians Lond. 1998 Nov-Dec; 32(6):510-1.
27. Davidson JA. Treatment of the patient with diabetes: importance of maintaining target HbA (1c) levels. Curr Med Res Opin. 2004 Dec; 20(12):1919-27.
28. International Diabetes Federation (IDF). Global guideline for type 2 diabetes; 2005.
29. Bergman RN. Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes. 1989 Dec; 38(12):1512-27.
30. Biermann E. DIACATOR: simulation of metabolic abnormalities of type II diabetes mellitus by use of a personal computer. Comput Methods Programs Biomed. 1994 Jan; 41(3-4):217-29.
31. Lehmann ED, Deutsch T. A physiological model of glucoseinsulin interaction in type 1 diabetes mellitus. J Biomed Eng. 1992 May; 14(3):235-42.
32. Swan GW. An optimal control model of diabetes mellitus. Bull Math Biol. 1982;44(6):793-808.
33. Bellazzi R, Arcelloni M, Ferrari P, Decata P, Hernando ME, Garcia A, Gazzaruso C, Gomez EJ, Larizza C, Fratino P, Stefanelli M. Management of patients with diabetes through information technology: tools for monitoring and control of the patients' metabolic behavior. Diabetes Technol Ther. 2004 Oct; 6(5):567-78.
34. Gomez EJ, Hernando ME, Garcia A, Del Pozo F, Cermeno J, Corcoy R, Brugues E, De Leiva A. Telemedicine as a tool for intensive management of diabetes: the DIABTel experience. Comput Methods Programs Biomed. 2002 Aug; 69(2):163-77.
35. Shea S, Starren J, Weinstock RS, Knudson PE, Teresi J, Holmes D, Palmas W, Field L, Goland R, Tuck C, Hripcsak G, Capps L, Liss D. Columbia University's Informatics for Diabetes Education and Telemedicine (IDEATel) Project: rationale and design. J Am Med Inform Assoc. 2002 Jan-Feb; 9(1):49-62.
36. Starren J, Hripcsak G, Sengupta S, Abbruscato CR, Knudson PE, Weinstock RS, Shea S. Columbia University's Informatics for Diabetes Education and Telemedicine (IDEATel) project: technical implementation. J Am Med Inform Assoc. 2002 Jan-Feb; 9(1):25-36.
37. Young RJ, Taylor J, Friede T, Hollis S, Mason JM, Lee P, Burns E, Long AF, Gambling T, New JP, Gibson JM. Pro-active call center treatment support (PACCTS) to improve glucose control in type 2 diabetes: a randomized controlled trial. Diabetes Care. 2005 Feb; 28(2):278-82.
38. Montori VM, Helgemoe PK, Guyatt GH, Dean DS, Leung TW, Smith SA, Kudva YC. Telecare for patients with type 1 diabetes and inadequate glycemic control: a randomized controlled trial and meta-analysis. Diabetes Care. 2004 May; 27(5):1088-94.
39. UK Prospective Diabetes Study (UKPDS) Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998 Sep. 12;352(9131):837-53.